Clearside biomedical inc.

Major-Pharmaceuticals

CLSD


900 North Point Parkway
Alpharetta , GA 30005

Executive/
Director

Price

  • Last Close
  • $ 0.96
    $ +0.01 0.84 %
    Jan 3, 2025
  • 52-Week High/Low
  • $2.02 - $0.68
  • YTD
  • 1.6%

  • Trading Volume
  • 68
  • Market Cap Full
  • $ 59.9M
  • Shares Outstanding
  • 62.4M
    Nov 8, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - -11.2% 53.3% 29% -5% -9.9% -16.7% -7.1% 31.6% 1.6%
Q2 -3.3% 14.7% 4.2% -28.8% 4% 97.2% -35.8% 7.7% -18.2% -
Q3 147.5% -4.1% -42.9% -37.8% 8% 24% -23.1% -22.3% -9.8% -
Q4 -48.5% -23.3% -82.4% 369% 80.3% -54.5% -0.9% 34.5% -12.9% -
J F M A M J J A S O N D
2025 1.6% - - - - - - - - - - -
2024 6.8% 12% 10% -16.2% 10.9% -10.5% -12.5% -9.8% - - - -11.2%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%-22%-85%189%-11%0%-59%4%-20%2%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.41 -0.62 -0.45 -0.07 -0.13 -0.13 -0.15
Q2 0.62 0.54 -0.65 -0.15 -0.13 -0.11 -0.13 -0.15
Q3 0.28 0.72 -0.75 -0.17 -0.05 -0.08 -0.13 -0.15
Q4 0.45 0.65 -0.67 -0.04 -0.14 0.33 -0.16 -
A 1.4 2.3 -2.7 -0.8 -0.4 0 -0.6 -0.45

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 36 44.9 57.4 60.1 61.4
Jun 31.9 37.6 44.9 57.6 60.2 61.7
Sep 32 37.8 46.3 59.5 60.2 62
Dec 32 41.1 48.4 59.7 60.2 62.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 1 - - 2 -
Total Asset Turnover - 0.7 0.4 0.1 -
Leverage
Debt Ratio - - - 0.2 0.2
Debt – Equity Ratio - - - 0.4 0.4
Interest Coverage -10 1 - -30 -
Equity multiplier 0.1 - - 0.1 -